Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 08 tags : Trial save search
CNH Industrial 2021 Fourth Quarter and Full Year Results
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
CNHI | $11.4 -1.55% -1.32% 15M
|
Producer Manufacturing
|
| O: -0.47%
H: 0.0%
C: 0.0%
trial results
Ocuphire Completes Enrollment in MIRA-3 Pivotal Phase 3 Clinical Trial for Nyxol® in RM and Announces Two Upcoming Medical Conference Presentations
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
OCUP | News | $1.52 -1.3% -1.32% 90K
|
Health Technology
|
| O: -0.34%
H: 8.47%
C: 8.47%
nyxol trial conference presentation phase 3 enroll
Global Industrial Robotics Market to Surpass US$ 69.1 Mn by end of 2027, Says Coherent Market Insights
Published: 2022-02-08 (Crawled : 19:00) - prnewswire.com
FANUF | $28.702 -7.69% 1.8K
|
Producer Manufacturing
|
| O: 1.48%
H: 3.92%
C: 3.87%
FANUY | $14.3 -2.11% 240K
|
Manufacturing
|
| O: 1.27%
H: 0.75%
C: 0.7%
DNZOY | $18.14 0.08% 76K
|
Manufacturing
|
| O: 2.93%
H: 0.58%
C: 0.58%
FARO | $18.65 -1.84% -1.88% 97K
|
Electronic Technology
|
| O: 1.02%
H: 1.28%
C: 1.08%
trial
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
Published: 2022-02-08 (Crawled : 17:00) - biospace.com/
MYMD | $2.92 14.06% 12.33% 100K
|
Manufacturing
|
| O: 0.23%
H: 1.16%
C: -5.35%
health phase 2 als trial positive
Karyopharm Announces Phase 3 SIENDO Study Meets Primary Endpoint with Statistically Significant Increase in Progression-Free Survival in Patients with Advanced or Recurrent Endometrial Cancer
Published: 2022-02-08 (Crawled : 13:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -12.31%
H: 5.26%
C: -4.21%
trial cancer phase 3
Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome
Published: 2022-02-08 (Crawled : 12:00) - globenewswire.com
BMRA | $0.691 -4.29% -4.49% 660K
|
Health Technology
|
| O: -0.71%
H: 2.14%
C: 0.95%
infoods treatment trial food topline results positive topline syndros
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.